Alternate TextTo enhance service speed and avoid tariff delays, we've opened a US warehouse. All US orders ship directly from our US facility.
Home > Products > Novel inhibitors

Novel inhibitors

You can also try the following methods, and our professionals will serve you Customized Consultation
Cat. No. Product Name Field of Application Chemical Structure
DCC3559 Nargenicin
Natural DnaE1 blocker, inducing a DNA damage response in Mycobacterium tuberculosis (Mtb) and inhibiting growth by blocking the replicative DNA polymerase, DnaE1
More description
DCC3558 N-arachidonoyl Taurine
Activator of the transient receptor potential vanilloid (TRPV) channels TRPV1 and TRPV4
More description
DCC3557 Napsagatran
Inhibitor of extrinsic and intrinsic thrombin generation, inhibiting clot-bound and free (fluid-phase thrombin)
More description
DCC3556 Napitane Mesylate
Antagonist of alpha-2 adrenergic receptors and inhibitor of the neuronal uptake of norepinephrine
More description
DCC3555 Napi2b Inhibitor 15
Novel Gut-Restricted Inhibitor of Intestinal Sodium-Dependent Phosphate Transport Protein 2b (NaPi2b) for the Treatment of Hyperphosphatemia
More description
DCC3554 Naphyrone Hydrochloride
Triple reuptake inhibitor
More description
DCC3553 Naphthyridine-azaquinolone
Novel repeat-structure-specific DNA ligand, specifically binding slipped-CAG DNA intermediates of expansion mutations
More description
DCC3552 Naph-o2
Novel fluorescent probe for detection of endogenously produced Naph-O2˙– in living cells and tissues
More description
DCC3551 Nalbuphine Hydrochloride
Mixed agonist/antagonist opioid modulator, binding with high affinity to the MOR and KOR, and having relatively low affinity for the DOR
More description
DCC3550 Nai003
Novel highly selective antibacterial agent against Propionibacterium acnes
More description
DCC3549 Nag-26
Novel potent full agonist for orexin receptor
More description
DCC3548 Nafoxidine
Partial estrogen antagonist, inhibiting angiogenesis in some tissues by blocking the effects of fibroblast growth factor (FGF) and vascular endothelial growth factor (VEGF), inducing oxidative stress, protein kinase C and calcium signaling
More description
DCC3547 Nadph Tetrasodium Salt
Electron donor and cofactor for many redox enzymes including nitric oxide synthetase
More description
DCC3546 Nadide
Coenzyme composed of ribosylnicotinamide 5'-diphosphate coupled to adenosine 5'-phosphate by pyrophosphate linkage
More description
DCC3545 N-adamantanylglycinamide Hbr
Novel antiviral agent against the replication of influenza virus A/H3N2 subtype in Madin-Darby canine kidney (MDCK) cells
More description
DCC3544 N-acetylloline
Derivative of loline
More description
DCC3543 Nabiximols
Delta-9-tetrahydrocannabinol (THC)/cannabidiol (CBD) combination for the treatment of multiple sclerosis (MS)-related moderate to severe spasticity
More description
DCC3542 Na-aaf
Alkylating agent, forming DNA adducts at the C-8 position in guanine, resulting in single strand breaks, demonstrating carcinogenic action
More description
DCC3541 N6-methyl-d3-adenosine
Deuterium labeled m6A used in important m6A physiological pathways related studies
More description
DCC3540 N6-allyladenosine
Novel RNA labeling probe through both metabolic and enzyme-assisted manners
More description
DCC3539 n00236460
Glucokinase activator (GKA)
More description
DCC3538 N,n-dimethylsphingosine
Competitive inhibitor of both SPHK1 and SPHK2
More description
DCC3537 Mzp-54
Novel potent and selective PROTAC degrader of BRD3/4
More description
DCC3536 Myxopyronin A
Bacterial RNA polymerase (RNAP) inhibitor
More description
DCC3535 Myrtucommulone
Inhibitor of the chaperonin activity of HSP60, correlating to LONP and LRP130 aggregation
More description
DCC3534 Myra-a
Novel inducer of apoptosis in a Myc-dependent manner, inhibiting Myc-driven transformation and disrupting MYC-Max interaction
More description
DCC3533 myovin-1
Novel potent, reversible and uncompetitive inhibitor of actin-stimulated ATPase activity of myosin V
More description
DCC3532 Myotoxin Ii (105-117)
Myotoxin II fragment
More description
DCC3531 My-d-4
Novel inhibitor of zinc finger DHHC domain-containing (zDHHC) enzymes
More description
DCC3530 Mycro2
Novel inhibitor of the protein-protein interactions between the bHLHZip proteins c-Myc and Max
More description

Customized Consultation X

Your information is safe with us. * Required Fields.

Your name
Company
Email
Procuct Name
Cat. No.
Remark
Verification code
Please fill out the characters in the picture
X